# COPA

## Overview
The COPA gene encodes the COPI coat complex subunit alpha, a critical component of the coatomer protein complex I (COPI). This protein is integral to the process of retrograde vesicular trafficking, facilitating the transport of proteins from the Golgi apparatus back to the endoplasmic reticulum (ER). This function is essential for maintaining cellular homeostasis and ensuring proper protein processing. The COPA protein is categorized as a component of the vesicular transport machinery, playing a pivotal role in vesicle formation and protein sorting. Beyond its transport functions, COPA is involved in immune regulation by modulating the STING pathway, thereby preventing excessive immune activation. Mutations in the COPA gene are associated with COPA syndrome, a disorder characterized by immune dysregulation and a spectrum of autoimmune and autoinflammatory symptoms (Vece2016Copa; Steiner2022Deficiency; Lepelley2020Mutations).

## Function
The COPA gene encodes the alpha subunit of the coatomer protein complex I (COPI), which is essential for retrograde vesicular trafficking from the Golgi apparatus to the endoplasmic reticulum (ER) in healthy human cells. This transport is crucial for maintaining cellular homeostasis and proper protein processing by ensuring the efficient retrieval of proteins, including those with dilysine motifs, back to the ER (Patwardhan2019An; Steiner2022Deficiency). COPA is active in the cytoplasm, particularly around the Golgi and ER membranes, where it plays a significant role in vesicle formation and protein sorting (Deng2020A).

In addition to its role in protein transport, COPA is involved in regulating the STING pathway, which is crucial for immune signaling. In healthy cells, COPA facilitates the retrieval of STING from the Golgi to the ER, preventing its accumulation and spontaneous activation, which could lead to inflammation (Steiner2022Deficiency; Deng2020A). This function is vital for maintaining normal immune responses and preventing excessive activation of the innate immune system (Lepelley2020Mutations). The proper functioning of COPA is necessary to avoid ER stress and maintain the structural integrity of the Golgi apparatus (Jensson2017COPA).

## Clinical Significance
Mutations in the COPA gene are linked to COPA syndrome, a rare autosomal dominant disorder characterized by immune dysregulation, leading to a combination of autoimmune and autoinflammatory symptoms. This syndrome is marked by interstitial lung disease, inflammatory arthritis, and immune-mediated kidney disease (Vece2016Copa; Zeng2021A). The mutations primarily occur in the WD40 domain of the COPA protein, affecting its function in retrograde transport from the Golgi to the endoplasmic reticulum (ER), which results in ER stress and activation of the unfolded protein response (Steiner2022Deficiency; Lepelley2020Mutations).

COPA syndrome is associated with elevated levels of type I interferons and interferon-stimulated genes, implicating the STING pathway in its pathogenesis (Kato2021Augmentation; Lepelley2020Mutations). The condition often presents early in life, with symptoms such as pulmonary hemorrhage, arthritis, and renal disease (Vece2016Copa; Jensson2017COPA). There is a noted female predominance in the expression of clinical symptoms, suggesting potential sex chromosome-related modifying factors (Vece2016Copa). Treatment strategies are still evolving, with STING inhibitors showing potential in reducing inflammation (Steiner2022Deficiency).

## Interactions
The COPA protein, a subunit of the COPI complex, is involved in retrograde transport between the Golgi apparatus and the endoplasmic reticulum (ER). It interacts with the stimulator of interferon genes (STING) protein, which is crucial for interferon signaling. Mutations in COPA, such as K230N, R233H, and D243G, disrupt its interaction with STING, leading to abnormal trafficking of STING to the Golgi and enhanced interferon signaling. This interaction was confirmed through co-immunoprecipitation assays, which showed that the interaction does not require the C-terminal tail of STING but is dependent on its transmembrane domains. This suggests an indirect interaction possibly mediated by an adaptor protein (Lepelley2020Mutations).

The COPA protein is also involved in the sorting and recruitment of STING to COPI-coated vesicles at the Golgi. Mutations in COPA may result in altered STING trafficking and sustained activation at the Golgi, contributing to the pathogenesis of COPA syndrome. This altered trafficking could lead to abnormal interferon signaling, highlighting the role of COPA in maintaining proper cellular signaling pathways (Lepelley2020Mutations).


## References


[1. (Steiner2022Deficiency) Annemarie Steiner, Katja Hrovat-Schaale, Ignazia Prigione, Chien-Hsiung Yu, Pawat Laohamonthonkul, Cassandra R. Harapas, Ronnie Ren Jie Low, Dominic De Nardo, Laura F. Dagley, Michael J. Mlodzianoski, Kelly L. Rogers, Thomas Zillinger, Gunther Hartmann, Michael P. Gantier, Marco Gattorno, Matthias Geyer, Stefano Volpi, Sophia Davidson, and Seth L. Masters. Deficiency in coatomer complex i causes aberrant activation of sting signalling. Nature Communications, April 2022. URL: http://dx.doi.org/10.1038/s41467-022-29946-6, doi:10.1038/s41467-022-29946-6. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29946-6)

2. (Deng2020A) A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome. This article has 3 citations.

[3. (Lepelley2020Mutations) Alice Lepelley, Maria José Martin-Niclós, Melvin Le Bihan, Joseph A. Marsh, Carolina Uggenti, Gillian I. Rice, Vincent Bondet, Darragh Duffy, Jonny Hertzog, Jan Rehwinkel, Serge Amselem, Siham Boulisfane-El Khalifi, Mary Brennan, Edwin Carter, Lucienne Chatenoud, Stéphanie Chhun, Aurore Coulomb l’Hermine, Marine Depp, Marie Legendre, Karen J. Mackenzie, Jonathan Marey, Catherine McDougall, Kathryn J. McKenzie, Thierry Jo Molina, Bénédicte Neven, Luis Seabra, Caroline Thumerelle, Marie Wislez, Nadia Nathan, Nicolas Manel, Yanick J. Crow, and Marie-Louise Frémond. Mutations in copa lead to abnormal trafficking of sting to the golgi and interferon signaling. Journal of Experimental Medicine, July 2020. URL: http://dx.doi.org/10.1084/jem.20200600, doi:10.1084/jem.20200600. This article has 145 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1084/jem.20200600)

[4. (Jensson2017COPA) Brynjar O. Jensson, Sif Hansdottir, Gudny A. Arnadottir, Gerald Sulem, Ragnar P. Kristjansson, Asmundur Oddsson, Stefania Benonisdottir, Hakon Jonsson, Agnar Helgason, Jona Saemundsdottir, Olafur T. Magnusson, Gisli Masson, Gudmundur A. Thorisson, Adalbjorg Jonasdottir, Aslaug Jonasdottir, Asgeir Sigurdsson, Ingileif Jonsdottir, Vigdis Petursdottir, Jon R. Kristinsson, Daniel F. Gudbjartsson, Unnur Thorsteinsdottir, Reynir Arngrimsson, Patrick Sulem, Gunnar Gudmundsson, and Kari Stefansson. Copa syndrome in an icelandic family caused by a recurrent missense mutation in copa. BMC Medical Genetics, November 2017. URL: http://dx.doi.org/10.1186/s12881-017-0490-8, doi:10.1186/s12881-017-0490-8. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-017-0490-8)

[5. (Patwardhan2019An) Anjali Patwardhan and Charles H. Spencer. An unprecedented copa gene mutation in two patients in the same family: comparative clinical analysis of newly reported patients with other known copa gene mutations. Pediatric Rheumatology, August 2019. URL: http://dx.doi.org/10.1186/s12969-019-0359-9, doi:10.1186/s12969-019-0359-9. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12969-019-0359-9)

[6. (Kato2021Augmentation) Takashi Kato, Masaki Yamamoto, Yoshitaka Honda, Takashi Orimo, Izumi Sasaki, Kohei Murakami, Hiroaki Hemmi, Yuri Fukuda‐Ohta, Kyoichi Isono, Saki Takayama, Hidenori Nakamura, Yoshiro Otsuki, Toshiaki Miyamoto, Junko Takita, Takahiro Yasumi, Ryuta Nishikomori, Tadashi Matsubayashi, Kazushi Izawa, and Tsuneyasu Kaisho. Augmentation of stimulator of interferon genes–induced type i interferon production in copa syndrome. Arthritis &amp; Rheumatology, 73(11):2105–2115, November 2021. URL: http://dx.doi.org/10.1002/art.41790, doi:10.1002/art.41790. This article has 20 citations.](https://doi.org/10.1002/art.41790)

[7. (Vece2016Copa) Timothy J. Vece, Levi B. Watkin, Sarah K. Nicholas, Debra Canter, Michael C. Braun, Robert Paul Guillerman, Karen W. Eldin, Grant Bertolet, Scott D. McKinley, Marietta de Guzman, Lisa R. Forbes, Ivan Chinn, and Jordan S. Orange. Copa syndrome: a novel autosomal dominant immune dysregulatory disease. Journal of Clinical Immunology, 36(4):377–387, April 2016. URL: http://dx.doi.org/10.1007/s10875-016-0271-8, doi:10.1007/s10875-016-0271-8. This article has 144 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-016-0271-8)

[8. (Zeng2021A) Jingxia Zeng, Jing Hao, Wei Zhou, Zhaoqun Zhou, and Hongjun Miao. A novel mutation c.841c&gt;t in copa syndrome of an 11-year-old boy: a case report and short literature review. Frontiers in Pediatrics, November 2021. URL: http://dx.doi.org/10.3389/fped.2021.773112, doi:10.3389/fped.2021.773112. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2021.773112)